Sara Kenkare-Mitra, President and Head of R&D at Alector, holds 291.71K shares in Alector (Ticker: ALEC), holds ― shares in Unicycive Therapeutics (Ticker: UNCY). Most recently, Sara Kenkare-Mitra Sold ― shares of Alector on Sep 04, 2024 for an estimated value of 67.96K.
What is the percentage of profitable transactions made by Sara Kenkare-Mitra?
The percentage of profitable transactions made by Sara Kenkare-Mitra is 71%.
What is the average return per transaction made by Sara Kenkare-Mitra?
The average return per transaction made by Sara Kenkare-Mitra is 9.90%.
What stocks does Sara Kenkare-Mitra hold?
Sara Kenkare-Mitra holds: ALEC, UNCY stocks.
What was Sara Kenkare-Mitra’s latest transaction?
Sara Kenkare-Mitra latest transaction was an Informative Sell of $67.96K.
What was Sara Kenkare-Mitra's most profitable transaction?
Sara Kenkare-Mitra’s most profitable transaction was an Informative Sell of ALEC stock on June 5, 2023. The return on the trade was 33.20%.
What is Sara Kenkare-Mitra's role in Alector?
Sara Kenkare-Mitra's role in Alector is President and Head of R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.